Arcosa Inc Stock Alpha and Beta Analysis
| ACA Stock | USD 110.31 1.69 1.56% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Arcosa Inc. It also helps investors analyze the systematic and unsystematic risks associated with investing in Arcosa over a specified time horizon. Remember, high Arcosa's alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Arcosa's market risk premium analysis include:
Beta 1.57 | Alpha 0.0221 | Risk 2.54 | Sharpe Ratio 0.0327 | Expected Return 0.0833 |
Arcosa Quarterly Cash And Equivalents |
|
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
Check out Arcosa Analysis, Arcosa Valuation, Arcosa Correlation, Arcosa Hype Analysis, Arcosa Volatility, Arcosa Price History and analyze Arcosa Performance. Arcosa Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Arcosa market risk premium is the additional return an investor will receive from holding Arcosa long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Arcosa. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Arcosa's performance over market.| α | 0.02 | β | 1.57 |
Arcosa expected buy-and-hold returns
Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of Arcosa's Buy-and-hold return. Our buy-and-hold chart shows how Arcosa performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.Arcosa Market Price Analysis
Market price analysis indicators help investors to evaluate how Arcosa stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Arcosa shares will generate the highest return on investment. By understating and applying Arcosa stock market price indicators, traders can identify Arcosa position entry and exit signals to maximize returns.
Arcosa Return and Market Media
The median price of Arcosa for the period between Thu, Dec 4, 2025 and Wed, Mar 4, 2026 is 111.37 with a coefficient of variation of 6.19. The daily time series for the period is distributed with a sample standard deviation of 7.06, arithmetic mean of 114.06, and mean deviation of 5.86. The Stock received a lot of media exposure during the period. Price Growth (%) |
| Timeline |
1 | JPMorgan Chase Co. Has 32.09 Million Stake in Arcosa, Inc. ACA | 12/03/2025 |
2 | Do Options Traders Know Something About Arcosa Stock We Dont | 12/26/2025 |
3 | Arcosa stock hits 52-week high at 113.27 USD By Investing.com - Investing.com India | 01/14/2026 |
4 | As Trump floats new health care savings, Congress is still deadlocked over its own proposals | 01/16/2026 |
5 | Im simply exhausted Im 55 and have 1.3 million for retirement. Can I retire next year | 01/21/2026 |
6 | In HelloNation, Health Insurance Expert David Wiley Explains Key Dates and ACA Protections | 01/22/2026 |
7 | ACA Group and Anduin Partner to Deliver Fully Integrated AMLKYC and Investor Onboarding Solution | 01/27/2026 |
| Arcosa dividend paid on 30th of January 2026 | 01/30/2026 |
8 | Securus Technologies Sets the Industry Agenda for Intelligence-Led Corrections at the 2026 ACA Winter Conference | 02/03/2026 |
9 | Ayrmid Appoints ACA Pharma as Exclusive Distributor for Omisirge across Greater China and Southeast Asia | 02/09/2026 |
10 | ACA Efile Deadline is Approaching Get the Efile Service with No TCC Required, with ez1095 | 02/12/2026 |
11 | Halfpricesoft.com Highlights ez1095 ACA Software as Critical Solution With 1095 Deadlines Fast Approaching | 02/19/2026 |
About Arcosa Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Arcosa or other stocks. Alpha measures the amount that position in Arcosa Inc has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
| 2023 | 2024 | 2025 | 2026 (projected) | Dividend Yield | 0.002445 | 0.002063 | 0.00192 | 0.003519 | Price To Sales Ratio | 1.74 | 1.83 | 1.81 | 0.95 |
Arcosa Upcoming Company Events
As portrayed in its financial statements, the presentation of Arcosa's financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Arcosa's leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of Arcosa's public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of Arcosa. Please utilize our Beneish M Score to check the likelihood of Arcosa's management manipulating its earnings.
| 22nd of February 2024 Upcoming Quarterly Report | View | |
| 25th of April 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 22nd of February 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Build Portfolio with Arcosa
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Check out Arcosa Analysis, Arcosa Valuation, Arcosa Correlation, Arcosa Hype Analysis, Arcosa Volatility, Arcosa Price History and analyze Arcosa Performance. You can also try the Price Transformation module to use Price Transformation models to analyze the depth of different equity instruments across global markets.
Arcosa technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.